U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H15FN2
Molecular Weight 206.2593
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 6-FLUORO-DMT

SMILES

CN(C)CCC1=CNC2=C1C=CC(F)=C2

InChI

InChIKey=DZXZPVGWRZCXDH-UHFFFAOYSA-N
InChI=1S/C12H15FN2/c1-15(2)6-5-9-8-14-12-7-10(13)3-4-11(9)12/h3-4,7-8,14H,5-6H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C12H15FN2
Molecular Weight 206.2593
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:57:15 GMT 2023
Edited
by admin
on Sat Dec 16 17:57:15 GMT 2023
Record UNII
J4CZH8D9EN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
6-FLUORO-DMT
Common Name English
2-(6-Fluoro-1H-indol-3-yl)-N,N-dimethylethan-1-amine
Systematic Name English
[2-(6-Fluoro-indol-3-yl)-ethyl]-dimethyl-amine
Systematic Name English
1H-Indole-3-ethanamine, 6-fluoro-N,N-dimethyl-
Systematic Name English
Indole, 3-[2-(dimethylamino)ethyl]-6-fluoro-
Systematic Name English
6-Fluoro-N,N-dimethyl-1H-indole-3-ethanamine
Systematic Name English
Code System Code Type Description
PUBCHEM
121013343
Created by admin on Sat Dec 16 17:57:18 GMT 2023 , Edited by admin on Sat Dec 16 17:57:18 GMT 2023
PRIMARY
CAS
1511-31-5
Created by admin on Sat Dec 16 17:57:18 GMT 2023 , Edited by admin on Sat Dec 16 17:57:18 GMT 2023
PRIMARY
WIKIPEDIA
6-Fluoro-DMT
Created by admin on Sat Dec 16 17:57:18 GMT 2023 , Edited by admin on Sat Dec 16 17:57:18 GMT 2023
PRIMARY
FDA UNII
J4CZH8D9EN
Created by admin on Sat Dec 16 17:57:18 GMT 2023 , Edited by admin on Sat Dec 16 17:57:18 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TRANSPORTER->LIGAND
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST
TARGET -> AGONIST